• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“为了我的整个家庭,我应该去弄清楚”:一份关于澳大利亚乳腺癌和/或卵巢癌高危个体接受遗传咨询和检测情况的报告。

"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.

作者信息

Wakefield Claire E, Ratnayake Paboda, Meiser Bettina, Suthers Graeme, Price Melanie A, Duffy Jessica, Tucker Kathy

机构信息

School of Women's and Children's Health, University of New South Wales, Sydney, Australia.

出版信息

Genet Test Mol Biomarkers. 2011 Jun;15(6):379-85. doi: 10.1089/gtmb.2010.0158. Epub 2011 Jan 23.

DOI:10.1089/gtmb.2010.0158
PMID:21254855
Abstract

CONTEXT

Despite proven benefits, the uptake of genetic counseling and testing by at-risk family members of BRCA1 and BRCA2 mutation carriers remains low.

AIMS

This study aimed to examine at-risk individuals' reported reasons for and against familial cancer clinic (FCC) attendance and genetic testing.

METHODS

Thirty-nine telephone interviews were conducted with relatives of high-risk mutation carriers, 23% (n = 9) of whom had not previously attended an FCC. Interview responses were analyzed using the frameworks of Miles and Huberman.

RESULTS

The reasons most commonly reported for FCC attendance were for clarification of risk status and to gain access to testing. While disinterest in testing was one reason for FCC nonattendance, several individuals were unaware of their risk (n = 3) or their eligibility to attend an FCC (n = 2), despite being notified of their risk status through their participation in a large-scale research project. Individuals' reasons for undergoing testing were in line with that reported elsewhere; however, concerns about discrimination and insurance were not reported in nontestees.

CONCLUSIONS

Current guidelines regarding notifying individuals discovered to be at increased risk in a research, rather than clinical setting, take a largely nondirective approach. However, this study demonstrates that individuals who receive a single letter notifying them of their risk may not understand/value the information they receive.

摘要

背景

尽管已证实有诸多益处,但携带BRCA1和BRCA2基因突变者的高危家庭成员接受遗传咨询和检测的比例仍然很低。

目的

本研究旨在调查高危个体报告的支持和反对前往家族癌症诊所(FCC)就诊及进行基因检测的原因。

方法

对高危突变携带者的亲属进行了39次电话访谈,其中23%(n = 9)的人此前未去过FCC。使用迈尔斯和休伯曼的框架对访谈回复进行了分析。

结果

报告的前往FCC就诊的最常见原因是为了明确风险状况并获得检测机会。虽然对检测不感兴趣是未前往FCC的一个原因,但有几个人尽管通过参与一个大型研究项目得知了自己的风险状况,却仍不知道自己的风险(n = 3)或无资格前往FCC(n = 2)。接受检测者进行检测的原因与其他地方报告的一致;然而,未接受检测者未报告对歧视和保险的担忧。

结论

目前关于在研究而非临床环境中通知被发现风险增加的个体的指南,在很大程度上采取了非指导性方法。然而,本研究表明,收到一封告知其风险的信件的个体可能并不理解/重视他们收到的信息。

相似文献

1
"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.“为了我的整个家庭,我应该去弄清楚”:一份关于澳大利亚乳腺癌和/或卵巢癌高危个体接受遗传咨询和检测情况的报告。
Genet Test Mol Biomarkers. 2011 Jun;15(6):379-85. doi: 10.1089/gtmb.2010.0158. Epub 2011 Jan 23.
2
Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.BRCA1和BRCA2基因突变基因检测后参与心理社会电话咨询的预测因素。
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):875-81.
3
Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.通过电话服务扩大BRCA1/2基因咨询的可及性:一项整群随机试验
J Natl Cancer Inst. 2014 Nov 5;106(12). doi: 10.1093/jnci/dju328. Print 2014 Dec.
4
Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.BRCA1和BRCA2基因突变检测结果呈阳性后的心理社会问题:焦点小组和需求评估调查的结果
CMAJ. 2001 Apr 3;164(7):1005-9.
5
Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.日本年轻乳腺癌患者风险评估、遗传咨询及基因检测中的相关问题
Breast Cancer. 2014 Nov;21(6):656-63. doi: 10.1007/s12282-013-0477-z. Epub 2013 Jun 11.
6
Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.以色列遗传性乳腺癌/卵巢癌的遗传咨询:心理社会影响及遗传信息留存情况
Am J Med Genet. 2002 Aug 1;111(2):147-51. doi: 10.1002/ajmg.10550.
7
Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.种族/族裔对遗传性乳腺癌和卵巢癌遗传咨询与检测的影响。
Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x.
8
Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.对基因咨询后患者不进行BRCA基因检测原因的大型前瞻性分析。
J Genet Couns. 2017 Aug;26(4):859-865. doi: 10.1007/s10897-016-0064-5. Epub 2017 Jan 16.
9
Using genetic analysis to individualize preventive measures for breast and ovarian cancers.利用基因分析为乳腺癌和卵巢癌个体化预防措施。
Nat Clin Pract Oncol. 2006 Apr;3(4):182-3. doi: 10.1038/ncponc0456.
10
Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.与个体决定退出乳腺癌和卵巢癌易感性基因检测相关的因素:对咨询的启示
Genet Test. 2007 Spring;11(1):45-54. doi: 10.1089/gte.2006.9998.

引用本文的文献

1
Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.利益相关者对克服林奇综合征级联检测障碍的观点:一项定性研究。
Cancer Prev Res (Phila). 2020 Dec;13(12):1037-1046. doi: 10.1158/1940-6207.CAPR-20-0141. Epub 2020 Jul 29.
2
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast Cancer.向研究参与者反馈个体基因研究结果:乳腺癌患者的接受情况及结果
JCO Precis Oncol. 2018;2. doi: 10.1200/po.17.00250. Epub 2018 Apr 16.
3
Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.
针对被告知癌症风险临床可操作研究结果的基因组研究参与者的决策辅助工具的开发与试点测试
J Genet Couns. 2018 Sep;27(5):1055-1066. doi: 10.1007/s10897-018-0223-y. Epub 2018 Feb 17.
4
Microtubule actin cross-linking factor 1, a novel potential target in cancer.微管肌动蛋白交联因子1,一种癌症中的新型潜在靶点。
Cancer Sci. 2017 Oct;108(10):1953-1958. doi: 10.1111/cas.13344. Epub 2017 Sep 21.
5
Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.为何被确定有遗传性乳腺癌风险的女性对癌症遗传咨询的利用率不高?患者对收到转诊信后的障碍的看法。
J Genet Couns. 2017 Aug;26(4):697-715. doi: 10.1007/s10897-016-0040-0. Epub 2016 Nov 8.
6
A model for patient-direct screening and referral for familial cancer risk.一种针对家族性癌症风险的患者直接筛查和转诊模式。
Fam Cancer. 2016 Oct;15(4):707-16. doi: 10.1007/s10689-016-9912-6.
7
Timing and context: important considerations in the return of genetic results to research participants.时机与背景:向研究参与者反馈基因检测结果时的重要考量因素
J Community Genet. 2016 Jan;7(1):11-20. doi: 10.1007/s12687-015-0231-7. Epub 2015 May 26.
8
Between personal and relational privacy: understanding the work of informed consent in cancer genetics in Brazil.在个人隐私与关系隐私之间:理解巴西癌症遗传学中知情同意的工作。
J Community Genet. 2015 Jul;6(3):287-93. doi: 10.1007/s12687-015-0234-4. Epub 2015 May 22.
9
Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australia.林奇综合征的知识、态度和转诊模式:对澳大利亚临床医生的调查。
J Pers Med. 2014 May 12;4(2):218-44. doi: 10.3390/jpm4020218.
10
All in the Family: Barriers and Motivators to the Use of Cancer Family History Questionnaires and the Impact on Attendance Rates.家庭因素:使用癌症家族病史问卷的障碍与动机及其对就诊率的影响
J Genet Couns. 2015 Oct;24(5):822-32. doi: 10.1007/s10897-014-9813-5. Epub 2015 Jan 7.